These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18623216)

  • 21. Development and validation of a gradient HPLC method for the determination of clindamycin and related compounds in a novel tablet formulation.
    Platzer DJ; White BA
    J Pharm Biomed Anal; 2006 Apr; 41(1):84-8. PubMed ID: 16298506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML; Berry MR; Nickerson B
    J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a dissolution test for rabeprazole sodium in coated tablets.
    Garcia CV; Paim CS; Steppe M; Schapoval EE
    J Pharm Biomed Anal; 2006 Jun; 41(3):833-7. PubMed ID: 16513316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies.
    Oliveira DC; Weigch A; Rolim CM
    Pharmazie; 2007 Feb; 62(2):96-100. PubMed ID: 17341026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In situ dissolution testing using potentiometric sensors.
    Peeters K; De Maesschalck R; Bohets H; Vanhoutte K; Nagels L
    Eur J Pharm Sci; 2008 Aug; 34(4-5):243-9. PubMed ID: 18539443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell.
    Motz SA; Schaefer UF; Balbach S; Eichinger T; Lehr CM
    Eur J Pharm Biopharm; 2007 May; 66(2):286-95. PubMed ID: 17156983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of variability in dissolution testing with USP apparatus 2.
    Gao Z; Moore TW; Smith AP; Doub WH; Westenberger BJ
    J Pharm Sci; 2007 Jul; 96(7):1794-801. PubMed ID: 17252609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test.
    Heigoldt U; Sommer F; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2010 Sep; 76(1):105-11. PubMed ID: 20472059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discriminatory dissolution method for quality control measurements of carbamazepine immediate release tablets based on in vitro--in vivo investigations.
    Xu C; Zou M; Wang Y; Liu Y; Yan J; Wu Y; Cheng G
    Drug Dev Ind Pharm; 2012 Jun; 38(6):679-88. PubMed ID: 21988132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of analytical methods involved in dissolution assays: acceptance limits and decision methodologies.
    Rozet E; Ziemons E; Marini RD; Boulanger B; Hubert P
    Anal Chim Acta; 2012 Nov; 751():44-51. PubMed ID: 23084050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms.
    Wang Y; Armenante PM
    J Pharm Sci; 2012 Feb; 101(2):746-60. PubMed ID: 22083630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of discriminating method of dissolution for fosamprenavir tablets based on in vivo data.
    Rossi RC; Dias CL; Bajerski L; Bergold AM; Fröehlich PE
    J Pharm Biomed Anal; 2011 Feb; 54(3):439-44. PubMed ID: 20943342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of Discriminative Dissolution Method for Metformin Immediate-Release Film-Coated Tablets.
    Mitrevska I; Achkoska T; Brezovska K; Toshev K; Dimitrovska A; Ugarkovic S
    J Anal Methods Chem; 2019; 2019():4296321. PubMed ID: 31886020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A crescent-shaped spindle for improved dissolution testing.
    Qureshi SA
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):55-65. PubMed ID: 20144452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-evaluation of in vitro dissolution techniques for supersaturating drug delivery systems.
    Bagchi S; Mukherjee T; Plakogiannis F
    Pharm Dev Technol; 2012; 17(4):477-82. PubMed ID: 21284575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging of tablet dissolution.
    Nott KP
    Eur J Pharm Biopharm; 2010 Jan; 74(1):78-83. PubMed ID: 19602436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations.
    Emami J; Ghassami N; Ahmadi F
    J Pharm Biomed Anal; 2006 Mar; 40(4):999-1005. PubMed ID: 16176866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of penicillamine in pharmaceuticals and human plasma by capillary electrophoresis with in-column fiber optics light-emitting diode induced fluorescence detection.
    Yang X; Yuan H; Wang C; Su X; Hu L; Xiao D
    J Pharm Biomed Anal; 2007 Oct; 45(2):362-6. PubMed ID: 17606355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Improvement of dissolution test using microdialysis method].
    Nagai N; Murao T; Ito Y
    Yakugaku Zasshi; 2009 Dec; 129(12):1515-21. PubMed ID: 19952531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.